An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations

Human Pathology

Volumn 44, Issue 10, 2013, Pages 2173-2179

  Vasilieva, Larisa E ^a   Papadhimitriou, Stefanos I ^b   Alexopoulou, Alexandra ^a   Pavlidis, Dimitris ^b   Kostopoulos, Ioannis ^b   Georgiakaki, Maria ^b   Xinopoulos, Dimitrios ^c   Romanos, Andreas ^d   Dourakis, Spyridon P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c 1st Department of Medical Oncology   (Greece)

^d HIPPOKRATION HOSPITAL   (Greece)

Author keywords

7q31; CCND1 amplification; INK4 deletion; Interphase cytogenetics; TP53 deletion

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BIOPSY; CANCER PATIENT; CHROMOSOME 17P; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; CLONE; COMPARATIVE STUDY; CYTOGENETICS; DIPLOIDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LIVER CELL CARCINOMA; MALE; SMEAR; TETRASOMY; TRISOMY;

7Q31; CCND1 AMPLIFICATION; INK4 DELETION; INTERPHASE CYTOGENETICS; TP53 DELETION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOPSY; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHROMOSOME ABERRATIONS; CYTODIAGNOSIS; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED;

EID: 84884418134     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.04.012     Document Type: Article

References (32)

1. L.E. Vasilieva, S.I. Papadhimitriou, and S.P. Dourakis Modern diagnostic approaches to cholangiocarcinoma Hepatobiliary Pancreat Dis Int 11 2012 349 359
2. E.G. Fritcher, B.R. Kipp, and K.C. Halling A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures Gastroenterology 136 2009 2180 2186
3. S.M. Selvaggi Biliary brushing cytology Cytopathology 15 2004 74 79
4. B.R. Kipp, L.M. Stadheim, and S.A. Halling A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures Am J Gastroenterol 99 2004 1675 1681
5. E.G. Fritcher, J.L. Caudil, and J.E. Blue Identification of malignant cytologic criteria in pancreatobiliary brushings with corresponding positive fluorescence in situ hybridization results Am J Clin Pathol 136 2011 442 449
6. J.H. Lim Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings AJR Am J Roentgenol 181 2003 819 827
7. P. Duesberg, and R. Li Multistep carcinogenesis: a chain reaction of aneuploidizations Cell Cycle 2 2003 202 210
8. A. Bergquist, B. Tribukait, H. Glaumann, and U. Broomé Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? J Hepatol 33 2000 873 877
9. S.Y. Bangarulingam, E. Bjornsson, and F. Enders Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis Hepatology 51 2010 174 180
10. B.R. Kipp, E.G. Fritcher, and A.C. Clayton Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography J Mol Diagn 12 2010 780 786
11. R.D. DeHaan, B.R. Kipp, T.C. Smyrk, S.C. Abraham, L.R. Roberts, and K.C. Halling An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas Hum Pathol 38 2007 491 499
12. T.A. Gonda, M.P. Glick, and A. Sethi Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures Gastrointest Endosc 75 2012 74 79
13. A.M. Rijken, J. Hu, and E.J. Perlman Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis Genes Chromosomes Cancer 26 1999 185 191
14. H. Abou-Rebyeh, H. Al-Abadi, S. Jonas, I. Rotter, W.O. Bechstein, and P. Neuhaus DNA analysis of cholangiocarcinoma cells: prognostic and clinical importance Cancer Detect Prev 26 2002 313 319
15. Y. Shimizu, A.J. Demetris, and S.M. Gollin Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells Int J Cancer 52 1992 252 260
16. S.F. Ding, J.D. Delhanty, L. Bowles, J.S. Dooley, C.B. Wood, and N.A. Habib Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma Br J Cancer 67 1993 1007 1010
17. K. Shiraishi, K. Okita, and T. Harada Comparative genomic hybridization analysis of genetic aberrations associated with development and progression of biliary tract carcinomas Cancer 91 2001 570 577
18. S.H. Koo, C.H. Ihm, K.C. Kwon, J.W. Park, J.M. Kim, and G. Kong Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma Cancer Genet Cytogenet 130 2001 22 28
19. J.Y. Lee, Y.N. Park, K.O. Uhm, S.Y. Park, and S.H. Park Genetic alterations in intrahepatic cholangiocarcinoma as revealed by degenerate oligonucleotide primed PCR-comparative genomic hybridization J Korean Med Sci 19 2004 682 687
20. K.O. Uhm, Y.N. Park, J.Y. Lee, D.S. Yoon, and S.H. Park Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization Cancer Genet Cytogenet 157 2005 37 41
21. U. Chuensumran, S. Wongkham, C. Pairojkul, S. Chauin, and S. Petmitr Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma World J Gastroenterol 13 2007 2986 2991
22. G. Miller, N.D. Socci, and D. Dhall Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract J Exp Clin Cancer Res 28 2009 62
23. N. Shafizadeh, J.P. Grenert, V. Sahai, and S. Kakar Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder Hum Pathol 41 2010 485 492
24. J.C. Nault, and J. Zucman-Rossi Genetics of hepatobiliary carcinogenesis Semin Liver Dis 31 2011 173 187
25. F.J. Stott, S. Bates, and M.C. James The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with TP53 and MDM2 EMBO J 17 1998 5001 5014
26. C.A. Schmitt, M.E. McCurrach, E. de Stanchina, R.R. Wallace-Brodeur, and S.W. Lowe INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling TP53 Genes Dev 13 1999 2670 2677
27. N.A. Heerema, H.N. Sather, and M.G. Sensel Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group Blood 94 1999 1537 1544
28. S.I. Papadhimitriou, S. Polychronopoulou, A.A. Tsakiridou, G. Androutsos, G.S. Paterakis, and F. Athanassiadou p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia J Pediatr Hematol Oncol 27 2005 675 677
29. S.A. Ahrendt, C.F. Eisenberger, and L. Yip Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma J Surg Res 84 1999 88 93
30. A. Tannapfel, F. Sommerer, and M. Benicke Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma J Pathol 197 2002 624 631
31. K. Sugimachi, S. Aishima, and K. Taguchi The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma J Hepatol 35 2001 74 79
32. H. Fujii, X.G. Zhu, and T. Matsumoto Genetic classification of combined hepatocellular-cholangiocarcinoma Hum Pathol 31 2000 1011 1017